newsfilter
← Latest News
GlobeNewswire·

PharmaTher Announces Update on FDA New Drug Application for Ketamine

FDA provided preliminary responses to questions contained in the clarification only post-CRL meeting scheduled for December 2, 2024 PharmaTher has decided to cancel the meeting as the FDA preliminary responses were